- Entry
- $2.75
- Now
- $1.82 -33.6%
- Target
- —
- Score
- —
GPL-1 is here to stay, demand will kept growing. However at this point, i hate NVO, as it is a value trap, and i hate LLY even more, it is just too expensive. The threat of price war and patent cliff is real too. Both are just not a good entry IMO. However, GLP-1 manufacture is not the only play. Currently, I'm exploring companies that fix the loose skin problem with skin-tightening treatments - AIRS, INMD, APYX, ESTA, EOLS. These …
— ORIGINAL POST ·
Exploring the "GLP-1 aesthetics basket"
· r/stocks
· Aug 18, 2026